Inhibition of huntingtin aggregation by its N-terminal 17-residue peptide and its analogs.

Arch Biochem Biophys

Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, 781 039, India. Electronic address:

Published: November 2021


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The N-terminal 17-residue stretch of huntingtin (htt) folds into an amphipathic α-helix. The htt-harboring polyQ peptides form oligomers that are mediated via the assembly of the htt α-helices. The oligomerization results in higher local concentration of the polyglutamine (polyQ) region, thereby facilitating amyloid formation. The htt co-assembles with the htt-harbouring polyQ peptides, thereby reducing the local polyQ concentration, and consequently inhibiting aggregation. This study presents the aggregation inhibition of the exon I region of pathogenic huntingtin by htt and its analogs. The C-terminal amidation of htt is found to be essential for activity. The htt peptides with free amino terminus and the acetylated amino terminus possess comparable activity. The htt analog, wherein the Leu7 and Ala10 are substituted with 2-aminoisobutyric acid residues, exhibits significantly higher activity than the native htt.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.abb.2021.109033DOI Listing

Publication Analysis

Top Keywords

n-terminal 17-residue
8
htt
8
huntingtin htt
8
polyq peptides
8
activity htt
8
amino terminus
8
inhibition huntingtin
4
huntingtin aggregation
4
aggregation n-terminal
4
17-residue peptide
4

Similar Publications

Inhibition of huntingtin aggregation by its N-terminal 17-residue peptide and its analogs.

Arch Biochem Biophys

November 2021

Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, 781 039, India. Electronic address:

The N-terminal 17-residue stretch of huntingtin (htt) folds into an amphipathic α-helix. The htt-harboring polyQ peptides form oligomers that are mediated via the assembly of the htt α-helices. The oligomerization results in higher local concentration of the polyglutamine (polyQ) region, thereby facilitating amyloid formation.

View Article and Find Full Text PDF

About 50% of human cancers across the globe arise due to a mutation in the p53 gene which gives rise to its functional inactive form, and in the rest of the cancer the efficacy of active p53 (wild-type) is hindered by MDM2-mediated degradation. Breakdown of the p53-MDM2 association may constitute an effective strategy to stimulate or reinstate the activity of wild type p53, thereby reviving the p53 tumor suppressor capability. S100A1 has been revealed to associate with the N-terminal domain of MDM2 and p53 protein.

View Article and Find Full Text PDF

The causative agent of Huntington's disease, the poly-Q homo-repeat in the N-terminal region of huntingtin (httex1), is flanked by a 17-residue-long fragment (N17) and a proline-rich region (PRR), which promote and inhibit the aggregation propensity of the protein, respectively, by poorly understood mechanisms. Based on experimental data obtained from site-specifically labeled NMR samples, we derived an ensemble model of httex1 that identified both flanking regions as opposing poly-Q secondary structure promoters. While N17 triggers helicity through a promiscuous hydrogen bond network involving the side chains of the first glutamines in the poly-Q tract, the PRR promotes extended conformations in neighboring glutamines.

View Article and Find Full Text PDF

Huntington's disease is a genetic neurodegenerative disorder characterized by the formation of amyloid fibrils of the huntingtin protein (htt). The 17-residue N-terminal region of htt (Nt) has been implicated in the formation of early phase oligomeric species, which may be neurotoxic. Because tertiary interactions with a downstream (C-terminal) polyproline (polyP) region of htt may disrupt the formation of oligomers, which are precursors to fibrillar species, the effect of co-incubation of a region of htt with a 10-residue polyP peptide on oligomerization and fibrillization has been examined by atomic force microscopy.

View Article and Find Full Text PDF

Inhibition of Huntingtin Exon-1 Aggregation by the Molecular Tweezer CLR01.

J Am Chem Soc

April 2017

Max-Planck-Institut für Kohlenforschung , 45470 Mülheim an der Ruhr, Germany.

Huntington's disease is a neurodegenerative disorder associated with the expansion of the polyglutamine tract in the exon-1 domain of the huntingtin protein (htt). Above a threshold of 37 glutamine residues, htt starts to aggregate in a nucleation-dependent manner. A 17-residue N-terminal fragment of htt (N17) has been suggested to play a crucial role in modulating the aggregation propensity and toxicity of htt.

View Article and Find Full Text PDF